Aug 20, 2025
Knight Announces Normal Course Issuer Bid
More Press Releases
More Featured Articles and Inverviews
Knight Therapeutics Inc is a specialty and generic drug manufacturing company. The company's principal business activity is focused on developing, acquiring, in-licensing, out-licensing, marketing, and distributing innovative pharmaceutical products, consumer health products, and medical devices in Canada and select international markets. Knight finances other life sciences companies across the globe in order to generate interest income, strengthen relationships in the life sciences industry, and to secure product distribution rights.
Latest News
Latest News
Outlook Reports world
Featured Stocks
Browse Companies
MARKETS
COMMODITIES
CURRENCIES